Market Volatility Continues on the Australia Market
The goal of every investor is to achieve good solid returns, but when striving to manage their own portfolio, the opposite often occurs. I believe there are two main reasons for this: firstly, the overwhelming majority want to be in control of their investments, and secondly investors want to rely on their own research.
The challenge with this is that the majority of investors lack the knowledge required to invest correctly, with many searching for that illusive stock that will provide the returns they are seeking. Unfortunately, it is this desire to be in control (without the right knowledge) that is costing investors dearly in terms of lost time and returns.
Based on my own research on the top 20 stocks in the Australian market, it is possible to outperform the index using a few simple rules. That said, many believe that the top 20 stocks are too expensive and prefer to gamble on the penny dreadfuls, although this does explain why most investors achieve returns well below their expectations.
We only need to look at the performance of the All Ordinaries Index this calendar year to prove my point of why investing in the top stocks will yield the returns investors seek. From 1 January this year, the market has risen approximately 19 per cent.
So, if an investor had held all top 20 shares over the same period, their portfolio would have achieved capital growth of 16 per cent plus dividends. With the average dividend yield paying around 4 per cent, investors would have achieved a total return of 20 per cent. Not bad when you consider that most investors are happy achieving a return of around 8 to 9 per cent per annum (as per the latest ASX Investor Study in 2017).
Of the top 20 stocks, CSL has achieved the biggest growth with 41 per cent while the only stock showing a negative return in the top 20 is S32 down, which is down around 19 percent. Currently, nine of the top 20 stocks have achieved capital growth of over 20 per cent.
While I don’t espouse the philosophy of buy and hold or to over diversifying a portfolio, what this does demonstrate is that it is easy to achieve good returns without too much effort or knowledge. That said, if investors want to achieve returns above this level, then it pays to get a good education that will enable them to do this.
So what are the top and bottom performing sectors in Australia this week?
Interestingly, Materials topped the list rising over 3 per cent, while Consumer Staples and Information Technology were both up over 1 per cent. The worst performing sectors have been Communication Services, Utilities and Industrials, all of which have been flat.
Looking at the top 100 stocks, surprisingly Pendal Group rose over 9 per cent on Wednesday despite announcing a profit downgrade and is so far up over 11 per cent for the week. CSR is also up over 9 per cent this week, while S32 is up over 7 per cent.
The worst performers this week include Medibank down over 6 per cent, Flight Centre down over 4 per cent after warning of a profit downgrade, and Atlas Arteria, which is down over 3 per cent.
So what can we expect moving forward?
The Australian market is once again displaying a lot of indecision as it continues to trade sideways with the market rising just over 2 per cent since 1 July this year. In that time, the All Ordinaries Index has achieved a new all-time high before falling nearly 7 percent only to rise up over 6 percent before, once again, falling another 4 per cent only to rise back up where it started for the financial year.
Given the continued volatility and uncertainty, it’s no wonder investors are getting frustrated with the market. However, right now it’s important for investors to be patient as the market will decide on a direction soon, with it more than likely rising over the next few months. But to confirm this, we need to see the All Ordinaries rise above 6,900 points. That said, it is still possible that the market will fall away over the next week or so into my earlier target of below 6,400 points before turning to rise up.
Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in book stores and online at www.wealthwithin.com.au
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.